Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety of Intravenous APL-2 in Healthy Volunteers

Trial Profile

Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety of Intravenous APL-2 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs APL 2 (Primary)
  • Indications Ischaemia; Paroxysmal nocturnal haemoglobinuria; Wet age-related macular degeneration
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jan 2017 Status changed from not yet recruiting to completed.
    • 30 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top